PlushCare vs Willow: Compare GLP-1 Programs & Pricing
Side-by-side PlushCare and Willow: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
PlushCare and Willow are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares PlushCare vs Willow to help you identify which service aligns best with your health goals, budget, and preferred level of clinical support.
Visit PlushCare
Explore Willow
PlushCare vs Willow: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| PlushCare | (Code: ) | — No | ||
| Willow | $299.00 | $399.00 | Best for Oral and Injectable (Code: ) | — No |
PlushCare vs Willow: Medical Process & Accessibility
PlushCare emphasizes a rapid, 15‑minute virtual intake, followed by clinician review and prescription issuance when appropriate. After approval, a partnered U.S. pharmacy ships compounded semaglutide or tirzepatide directly to the patient’s door. Willow adds a structured onboarding questionnaire, a mandatory baseline lab review, and scheduled tele‑follow‑ups to fine‑tune dosing over the first 12 weeks. Both platforms operate fully online, are covered by most private insurers for virtual visits, and comply with FDA regulations for compounded GLP‑1 medications.
PlushCare vs Willow: Pricing Comparison
PlushCare does not publicly list a starting price for semaglutide or tirzepatide on its website, opting instead for a personalized quote after the medical intake. Willow advertises a clear‑cut starting price of $299.00 for semaglutide and $399.00 for tirzepatide. Because Willow’s figures are the only disclosed amounts, they appear lower by default. Both companies state that no membership fee is required to access their GLP‑1 programs, though Willow highlights a “Best for Oral and Injectable” promotional focus aimed at patients who may need both formulation types.
PlushCare vs Willow: Clinical Oversight & Support
Both providers connect patients with board‑certified physicians or nurse practitioners who are authorized to prescribe GLP‑1 therapies. PlushCare typically completes the prescription within 24‑48 hours of the tele‑visit, offering a brief email follow‑up to confirm medication receipt. Willow builds a longer‑term care plan, including monthly video check‑ins, dose‑adjustment algorithms, and access to a dedicated care coordinator for questions about side effects, diet, or exercise. This tiered support can be especially valuable for new users who experience nausea or other early‑treatment symptoms.
Book a Consultation with PlushCare
PlushCare vs Willow: Medication Quality & Safety
Each service partners with FDA‑registered compounding pharmacies that follow United States Pharmacopeia (USP) standards. While the products are not identical to brand‑name Wegovy® (semaglutide) or Mounjaro® (tirzepatide), they contain the same active ingredient in equivalent dosages. Both companies require a licensed prescriber to confirm diagnosis of obesity (BMI ≥ 30 kg/m² or BMI ≥ 27 kg/m² with comorbidities) before dispensing, ensuring alignment with FDA‑approved indications for GLP‑1 therapy.
PlushCare vs Willow: Customer Experience
Patient reviews frequently cite PlushCare for its low‑cost entry point and swift onboarding, making it attractive for users who want to test GLP‑1 therapy without a lengthy enrollment process. Conversely, Willow garners praise for its proactive communication, educational webinars, and personalized dose‑titration plans that many users feel improve adherence and weight‑loss outcomes. Shipping times for both providers average 5‑7 business days after prescription approval, with tracking available through the partnered pharmacy.
PlushCare vs Willow: Final Verdict
Choose PlushCare if you prioritize a quick, cost‑transparent entry into GLP‑1 therapy and are comfortable managing follow‑up care primarily through asynchronous messaging. Opt for Willow if you value a structured, clinician‑driven program with regular video visits, detailed dose‑adjustment guidance, and a clear pricing sheet from the outset. Both platforms are legally compliant, employ licensed U.S. prescribers, and ship FDA‑compliant compounded medications nationwide.
Join PlushCare
Get Started with Willow
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Starts at $146/mo (6‑month plan)
- Affordable Semaglutide injections
- Klarna / AfterPay / Affirm supported
- Personalized dosing to reach goals
From $179 + free FedEx
- Approval within ~4 hours*
- Semaglutide & Tirzepatide available
- Price‑lock: same price any dose
Free consult ($75 value)
- GLP‑1 ID Protocol — 46% faster*
- 4.9★ Google & Trustpilot
- No‑obligation evaluation
$120 OFF First Month
- GLP‑1 meds delivered to your door
- Refund if you don’t lose weight
- Doctor‑approved, U.S. clinicians
Save $70 (Code: Explore)
- Ozempic®, Tirzepatide & Semaglutide
- Instant approval, ship ≤ 3 days
- No membership fees
From $155/mo (12‑month plan)
- No insurance or membership required
- Quick approval — no waitlist
- Brand & compounded available
$50 Off First Month
- 2‑minute quiz, $50 off month one
- Prescription in ≤ 24 hours
- Cancel or change anytime
Pay $199 first month
- Free overnight shipping
- Avg. 14% weight loss*
- No insurance needed
$120 OFF First Month
- Affordable access to treatments
- Doctor‑supervised programs
- Clear pricing
$50 OFF First Month
- Streamlined treatment process
- Holistic program
- Mobile‑friendly platform
Programs available
- 100% online evaluation
- Provider messaging & check‑ins
- Fast‑track programs
From $249 / month
- Certified GLP‑1 providers
- Licensed consultations
- Nationwide coverage